Congressional report slams FDA, drugmaker over approval of Alzheimer’s drug Aduhelm
Dec 29, 2022
The controversy over aducanumab (Aduhelm) stretches back to its June 2021 approval by the US Food and Drug Administration.
Drop in mortality seen with AChEI, memantine in dementia with Lewy bodies
Dec 14, 2022
Risk for death, unplanned hospital admission significantly lower for those taking AChEIs only or taking AChEIs and memantine
Study explores impact of FDA approval of aducanumab on trial participation
Dec 06, 2022
Individuals who were independently aware of the FDA decision demonstrated a reduced willingness to participate.
Review links hearing aid devices with reduced cognitive decline
Dec 06, 2022
Further, the use of devices is linked to a 3% improvement in cognitive test scores in the short term.
Alzheimer’s experts throw support behind experimental drug despite adverse events, deaths
By
Kimberly Bonvissuto
Dec 01, 2022
Alzheimer’s disease experts are throwing their support behind the drug lecanemab, despite reports of two deaths tied to the experimental monoclonal antibody medication.
Progress made in Alzheimer’s research and lifestyle interventions, NIH says
By
Kimberly Bonvissuto
Nov 30, 2022
The burden of Alzheimer’s disease and related dementias is significant, according to the National Institutes of Health. But scientists have made progress in drug development, lifestyle interventions,...
A stumbling block on the way to an Alzheimer’s cure
By
Lois A. Bowers
Nov 14, 2022
In a new study, 56% of participants said they were not likely to take part in a trial of a dementia-prevention drug. Senior living may be able to play a role in decreasing that percentage.
More news for Friday, Nov. 11
By
Kimberly Bonvissuto
Nov 11, 2022
RecallCue wins Gold in McKnight’s Tech Awards for dementia clock … Delinquent senior housing loans continued to edge lower in 2Q: NIC … Robots may help older adults with disabilities delay move to...
2000 to 2016 saw decline in dementia in US older adults
Nov 09, 2022
Education was found to be an important statistical factor contributing to the reduction in dementia.
‘Substantial’ decline in dementia rates due in part to higher education levels: study
By
Kimberly Bonvissuto
Nov 08, 2022
The prevalence of dementia in older adults in the United States declined 30% between 2000 and 2016, possibly due to rising education levels, a reduction in smoking and better treatment of cardiovascular...